IP Library › Granted Patent US 12,257,023
Granted Patent B1
US 12,257,023 · App. 17/157,475 · Granted Mar 25, 2025

Wearable stress testing device

Inventors: Devin Warner Miller (Morgan, UT); David Rich Miller (Morgan, UT); Jeffrey Michael Lee (Morgan, UT)
Assignee: JRE Star Investment Holdings, LLC
A61B5/0022A61B5/0205A61B5/1118A61B5/4884A61B5/6823A61B5/6824A61B5/6831A61B5/4848A61B5/7275
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,257,023
App. No.
17/157,475
Granted
Mar 25, 2025
Kind
B1
Abstract

Described herein are apparatuses and methods for measuring stress with a wearable device. In one apparatus, a wearable device includes a housing formed and shaped to affix to a user, a sensor integrated into the housing operable to engage a body of the user to take physiological measurements of the user over a threshold period of time to obtain physiological data, and a processing device coupled to the sensor. The processing device may be operable to receive, from the sensor, a first physiological data; receive, from the sensor, a second physiological data; determine a correlation between the first physiological data and the second physiological data; and determine a stress level of a bodily system of the user based on the correlation.

Claims (75)

1. A wearable device comprising:

a housing shaped to be coupled to a body of a user;

a sensor interface disposed in the housing to engage the body of the user to receive environmental measurements from the wearable device and physiological measurements of the user comprising a first physiological measurement, a second physiological measurement, and a third physiological measurement of the user;

a memory device, coupled to the sensor interface, the memory device to store the first physiological measurement, the second physiological measurement, and the third physiological measurement; and

a processing device coupled to the sensor interface, wherein the processing device is operable to:

determine a first medical status of the user corresponding to a first individualized baseline unique to a physiology of the user, the first individualized baseline being based on the first physiological measurement received from the sensor interface;

determine a second medical status of the user based on the second physiological measurement received from the sensor interface, wherein the second physiological measurement exceeds a first threshold of change from the first individualized baseline;

receive, from an input device, a first medication information indicative of a medication administered to the user;

determine that the medication is administered to the user based on the first medication information;

in response to determining that the medication is administered to the user, receive the third physiological measurement from the sensor interface;

calculate a difference between the second physiological measurement and the third physiological measurement;

determine a change in stress level of the user based on the environmental measurements;

determine a medication effectiveness based on the change in the stress level of the user in view of the environmental measurements and the difference between the second physiological measurement and the third physiological measurement, the medication effectiveness indicative of an improvement of the user from the second medical status, a lack of improvement of the second medical status, a determination of whether the medication has taken effect, and a side effect of the medication;

communicate to a user device or a third-party device the determined medication effectiveness, wherein the processing device is configured to normalize effects of the medication on the medical measurements over a time period.

2. The wearable device of claim 1 , wherein:

the sensor interface is further operable to receive the environmental measurement;

the memory device is further operable to store the environmental measurement; and

the processing device is further operable to:

determine a correlation between the second medical status and the environmental measurement; and

associate the environmental measurement with the second medical status based on the correlation.

3. The wearable device of claim 1 , wherein the processing device is further operable to:

determine that the second medical status is indicative of a first occurrence of a medical event;

determine that a third medical status is indicative of a second occurrence of the medical event; and

determine the efficacy of the medication based on a pattern between the first occurrence of the medical event and the second occurrence of the medical event.

4. The wearable device of claim 3 , wherein:

the wearable device is communicatively coupled to an external device; and the processing device is further operable to:

send or receive, from the external device, user information, wherein the user information indicates at least one of the first medical status or the second medical status of the user; and

display the user information indicating at least one of the first medical status or the second medical status of the user.

5. The wearable device of claim 1 , wherein:

the sensor interface is further operable to receive the second physiological measurement during an activity occurring concurrently with the second physiological measurement; and

the processing device is further operable to:

determine that a change from the first individualized baseline is due to the activity occurring concurrently with the second physiological measurement; and

communicate to the user a first indication to alter the activity occurring concurrently with the second physiological measurement.

6. The wearable device of claim 5 , further comprising a sensory indicator is operable to communicate to the user a second indication to alter the activity occurring concurrently with the second physiological measurement.

7. The wearable device of claim 1 , wherein:

the sensor interface is further operable to receive a movement measurement of the user; and

the processing device is further operable to:

determine an exertion level of the user based on the movement measurement;

associate a change from the first individualized baseline with the exertion level; and

predict an occurrence of another medical event of the user based on the exertion level.

8. A wearable device configured to:

receive, from an input device, a first medication information indicative of administration of a medication to a user;

receive, from the input device, environmental measurements;

determine a first medical status of the user before the medication is administered to the user based on a first physiological measurement received from a sensor interface and,

determine that the medication is administered to the user based on the first medication information and;

determine a second medical status of the user based on a second physiological measurement received from a sensor interface,

determine a change in stress level of the user based on the environmental measurements;

determine a medication effectiveness based on the change in the stress level of the user based on the environmental measurements and the difference between the second physiological measurement and the third physiological measurement, the medication effectiveness indicative of an improvement of the user from the second medical status, a lack of improvement of the second medical status, a determination of whether the medication has taken effect, and a side effect of the medication;

communicate, to the user or an external device, the medication effectiveness, and

wherein:

effects of the medication on the medical measurements are normalized over a time period.

9. The wearable device of claim 8 , wherein communicating the efficacy of the medication further comprises displaying, on a display of the wearable device, an indication representative of the efficacy of the medication.

10. The wearable device of claim 8 , wherein the wearable device is configured to determine a type of physical activity of the user and the efficacy of the medication is based, at least in part, on the type of physical activity of the user.

11. The wearable device of claim 10 , wherein the wearable device is configured to communicate a second indication to reduce or to cease the type of physical activity.

12. The wearable device of claim 8 , wherein the wearable device is configured to:

detect a movement measurement; and

determine an exertion level of the user, wherein the exertion level is based on:

the movement measurement; and

the efficacy of the medication.

13. The wearable device of claim 8 , wherein the wearable device is configured to determine the efficacy of the medication based on the environmental measurement detected by the wearable device.

14. The wearable device of claim 8 , wherein the wearable device is configured to determine the efficacy of the medication in view of third-party data received via a communication network.

15. A method comprising:

detecting, by a wearable device, a first physiological measurement from a user received from a sensor interface to set an individualized baseline unique to a physiology of the user;

detecting, by the wearable device, a second physiological measurement from the user received from a sensor interface after detection of the first physiological measurement, wherein the second physiological measurement exceeds a threshold of change from the individualized baseline;

detecting, by the wearable device, environmental measurements;

detecting, by the wearable device, a third physiological measurement from the user received from the sensor interface in response to administration of a medication to the user and after detection of the first physiological measurement wherein

effects of the medication on the medical measurements are normalized over a time period; and

determine a change in stress level of the user based on the environmental measurements;

determine a medication effectiveness based on the change in the stress level of the user based on the environmental measurements and the difference between the second physiological measurement and the third physiological measurement, the medication effectiveness indicative of an improvement of the user from the second medical status, a lack of improvement of the second medical status, a determination of whether the medication has taken effect, and a side effect of the medication;

communicating, by the wearable device, the medication effectiveness.

16. The method of claim 15 , further comprising calculating the efficacy of the medication further based, at least in part, on the environmental measurements corresponding to at least one of the first physiological measurement or the second physiological measurement.

17. The method of claim 15 , further comprising calculating the efficacy of the medication further based, at least in part, on a detected type of activity corresponding to at least one of the first physiological measurement, the second physiological measurement, or the third physiological measurement.

18. The method of claim 15 , further comprising calculating the efficacy of the medication further based, at least in part, on a detected exertion level of the user corresponding to at least one of the first physiological measurement, the second physiological measurement, or the third physiological measurement.

19. The method of claim 15 , wherein detecting at least one of the first physiological measurement, the second physiological measurement occurs on a continuous or semi-continuous basis to detect relative changes in the physiology of the user.

20. The method of claim 15 , further comprising providing to the user, by the wearable device, a recommendation associated with the medication based on at least one of the physiological measurement, the second physiological measurement, or the third physiological measurement.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2025
From: HALO WEARABLES, LLC
To: JRE STAR INVESTMENT HOLDINGS, LLC
Reel/Frame 069764/0353 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2024
From: MILLER, DEVIN WARNER; MILLER, DAVID RICH; LEE, JEFFREY MICHAEL
To: HALO WEARABLES, LLC
Reel/Frame 069708/0413 →
Continuity (2)
Division 14697452 · Apr 27, 2015
Provisional Application 61984039 · Apr 25, 2014
References Cited (83)
US 6605038B1 · Teller et al. · 2003 [cited by applicant]
US 7033321B1 · Sarvazyan · 2006 [cited by applicant]
US 7285090B2 · Stivoric et al. · 2007 [cited by applicant]
US 7539533B2 · Tran · 2009 [cited by examiner]
US 7594889B2 · St. Ores · 2009 [cited by examiner]
US 7689437B1 · Teller et al. · 2010 [cited by applicant]
US 7698157B2 · Ghouri · 2010 [cited by examiner]
US 7959567B2 · Stivoric et al. · 2011 [cited by applicant]
US 8103333B2 · Tran · 2012 [cited by examiner]
US 8157730B2 · LeBoeuf · 2012 [cited by examiner]
US 8271296B2 · Li · 2012 [cited by examiner]
US 8323188B2 · Tran · 2012 [cited by examiner]
US 8323191B2 · Bodlaender et al. · 2012 [cited by applicant]
US 8398546B2 · Pacione et al. · 2013 [cited by applicant]
US 8529447B2 · Jain et al. · 2013 [cited by applicant]
US 8538510B2 · Toledo et al. · 2013 [cited by applicant]
US 8540629B2 · Jain et al. · 2013 [cited by applicant]
US 8617067B2 · Jain · 2013 [cited by examiner]
US 8622899B2 · Jain · 2014 [cited by examiner]
US 8622901B2 · Jain et al. · 2014 [cited by applicant]
US 8684900B2 · Tran · 2014 [cited by examiner]
US 8702607B2 · LeBoeuf · 2014 [cited by examiner]
US 8821416B2 · Johansson · 2014 [cited by examiner]
US 8862211B2 · Toledo et al. · 2014 [cited by applicant]
US 8870766B2 · Stivoric et al. · 2014 [cited by applicant]
US 8961413B2 · Teller et al. · 2015 [cited by applicant]
US 8961414B2 · Teller et al. · 2015 [cited by applicant]
US 8961415B2 · LeBoeuf et al. · 2015 [cited by applicant]
US 9028405B2 · Tran · 2015 [cited by applicant]
US 9033875B2 · Teller et al. · 2015 [cited by applicant]
US 9307941B2 · Johansson · 2016 [cited by examiner]
US 20050192488A1 · Bryenton et al. · 2005 [cited by applicant]
US 20050234356A1 · Rowlandson et al. · 2005 [cited by applicant]
US 20050245839A1 · Stivoric et al. · 2005 [cited by applicant]
US 20060058593A1 · Drinan et al. · 2006 [cited by applicant]
US 20060115429A1 · Afeyan · 2006 [cited by examiner]
US 20070099203A1 · Zhang · 2007 [cited by examiner]
US 20070219059A1 · Schwartz et al. · 2007 [cited by applicant]
US 20070273504A1 · Tran · 2007 [cited by applicant]
US 20070276270A1 · Tran · 2007 [cited by applicant]
US 20080001735A1 · Tran · 2008 [cited by applicant]
US 20080039700A1 · Drinan et al. · 2008 [cited by applicant]
US 20080051843A1 · Li et al. · 2008 [cited by applicant]
US 20080146890A1 · LeBoeuf et al. · 2008 [cited by applicant]
US 20080146892A1 · LeBoeuf et al. · 2008 [cited by applicant]
US 20080270071A1 · Marvasti et al. · 2008 [cited by applicant]
US 20090005657A1 · Bodlaender et al. · 2009 [cited by applicant]
US 20090088611A1 · Buschmann et al. · 2009 [cited by applicant]
US 20090227876A1 · Tran · 2009 [cited by applicant]
US 20090318820A1 · Toledo et al. · 2009 [cited by applicant]
US 20110301441A1 · Bandic et al. · 2011 [cited by applicant]
US 20120095352A1 · Tran · 2012 [cited by applicant]
US 20120123232A1 · Najarian et al. · 2012 [cited by applicant]
US 20120150052A1 · Buchheim et al. · 2012 [cited by applicant]
US 20120245439A1 · Andre · 2012 [cited by examiner]
US 20120289791A1 · Jain · 2012 [cited by examiner]
US 20120289794A1 · Jain et al. · 2012 [cited by applicant]
US 20130041290A1 · Kording et al. · 2013 [cited by applicant]
US 20130172691A1 · Tran · 2013 [cited by applicant]
US 20140018641A1 · Yoshino et al. · 2014 [cited by applicant]
US 20140031709A1 · Toledo et al. · 2014 [cited by applicant]
US 20140035761A1 · Burton · 2014 [cited by applicant]
US 20140058280A1 · Chefles et al. · 2014 [cited by applicant]
US 20140128715A1 · Banet et al. · 2014 [cited by applicant]
US 20140143064A1 · Tran · 2014 [cited by applicant]
US 20140221792A1 · Miller et al. · 2014 [cited by applicant]
US 20150120205A1 · Jeon et al. · 2015 [cited by applicant]
US 20150126845A1 · Jin et al. · 2015 [cited by applicant]
US 20150289820A1 · Miller et al. · 2015 [cited by applicant]
US 20150305675A1 · Miller et al. · 2015 [cited by applicant]
US 20160051191A1 · Miller et al. · 2016 [cited by applicant]
US 20160128627A1 · Demos et al. · 2016 [cited by applicant]
U.S. Appl. No. 14/697,452, mailed Jun. 27, 2016, Office Action. [cited by applicant]
U.S. Appl. No. 14/697,452, mailed Mar. 9, 2017, Office Action. [cited by applicant]
U.S. Appl. No. 14/697,452, mailed Jul. 19, 2018, Office Action. [cited by applicant]
U.S. Appl. No. 14/697,452, mailed Mar. 21, 2019, Office Action. [cited by applicant]
U.S. Appl. No. 14/697,452, mailed Nov. 18, 2019, Office Action. [cited by applicant]
U.S. Appl. No. 14/697,452, mailed Sep. 3, 2020, Notice of Allowance. [cited by applicant]
U.S. Appl. No. 14/697,452, mailed Jan. 6, 2021, Issue Notification. [cited by applicant]
U.S. Appl. No. 17/157,478, mailed Mar. 29, 2023, Office Action. [cited by applicant]
U.S. Appl. No. 17/157,478, mailed Oct. 23, 2023, Office Action. [cited by applicant]
U.S. Appl. No. 17/157,478, mailed Dec. 20, 2023, Office Action. [cited by applicant]
U.S. Appl. No. 17/157,478, mailed Aug. 19, 2024, Notice of Allowance. [cited by applicant]